Location: Frederick MD, St Louis MO, Springfield MO,
Sponsor: Elephas
Sex: All
Age: 18+
Code: NCT07327489
Recruiting
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
for
FIGO Stage III and IV Ovarian Cancer, Fallopian Tube Cancers,
Location: New York NY, Durham NC, Rochester MN, Irvine CA,
Sponsor: TORL Biotherapeutics, LLC
Sex: Female
Age: 18 - 70+
Code: NCT07322094
Phase1, Phase2, Recruiting
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
for
HPV Infection, HPV 16 Infection, High Risk HPV,
Location: New Haven CT, Akron OH, Minneapolis MN
Sponsor: Qurasense
Sex: Female
Age: 25+
Code: NCT07281599
Recruiting
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
for
Head and Neck Squamous Cell Carcinoma HNSCC,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Sutro Biopharma, Inc.
Sex: All
Age: 18+
Code: NCT07227168
Phase1, Recruiting
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
for
Breast Cancer, Cervical Cancer, Bladder Cancer,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 65+
Code: NCT07227077
Recruiting
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Location: Boston MA, New Haven CT, Hackensack NJ, Philadelphia PA,
Sponsor: Normunity AccelCo, Inc.
Sex: All
Age: 18+
Code: NCT07182149
Phase1, Recruiting
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
for
Renal Cell Carcinoma, Non Small Cell Lung Cancer, Melanoma,
Location: Pittsburgh PA
Sponsor: Diwakar Davar
Sex: All
Age: 18+
Code: NCT07223424
Phase2, Recruiting
Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS
for
Uterine Leiomyosarcoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT07076186
Phase2, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer